Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats

Hepatology

Volumn 28, Issue 5, 1998, Pages 1269-1274

  Calès, Paul ^a,c   Oberti, Frédéric ^a   Veal, Nary ^a   Fort, Joël ^a   Kaassis, Mehdi ^a   Moal, Frédéric ^a   Aubé, Christophe ^a   Vuillenin, Eric ^a   Pilette, Christophe ^a   Rifflet, Hervé ^a,b   Trouvé, Renaud ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b CHG   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLNITROSAMINE; OCTREOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; DIAGNOSTIC ACCURACY; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SPLENORENAL SHUNT; ULTRASOUND THERAPY;

ANIMALS; BLOOD FLOW VELOCITY; COLLATERAL CIRCULATION; HEMOSTATICS; HYPERTENSION, PORTAL; KIDNEY; MALE; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SPLEEN; SPLENORENAL SHUNT, SURGICAL; ULTRASONOGRAPHY;

EID: 17344373896     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280515     Document Type: Article

References (23)

1. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol 1992;263:G544-G550.
2. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat using γ-labeled microspheres. Am J Physiol 1981;240:G371-G375.
3. Lee FY, Colombato L, Albillos A, Groszmann J. Administration of N-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993;105:1464-1470.
4. McCormick P, Greenslade L, Chin J, Dick R, McIntyre N, Burroughs A. The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1993;10:839-843.
5. D'Almeida MS, Gaudin C, Lebrec D. Validation of 1- and 2-mm transit time ultrasound flow probes on mesenteric artery and aorta of rats. Am J Physiol 1995;268:H1368-H1372.
6. D'Almeida MS, Cailmail S, Lebrcc D. Validation of transit-time ultrasonic flow probes to directly measure portal blood flow in conscious rats. Am J Physiol 1996;271:H2701-H2709.
7. Halvorsen JF, Myking AO. The porto-systemic collateral pattern in the rat. Eur Surg Res 1974;6:183-195.
8. Lebrec D. Animal models of portal hypertension. In: Okuda K, Benhamou JP, eds. Portal Hypertension: Clinical and Physiological Aspects. Springer-Verlag, Tokyo, 1991:101-13.
9. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED. Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol 1980;239:H443-H449.
10. Geraghty JG, Angerson WJ, Carter DC. Portal venous pressure and portosystemic shunting in experimental portal hypertension. Am J Physiol 1989;257:G52-G57.
11. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press, 1989.
12. O'Connel DL, Dobson AJ. General observer-agreement measures on individual subjects and groups of subjects. Biometrics 1984;40:973-983.
13. Calès P, Braillon A, Jiron MI, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis, lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1984;1:37-46.
14. Tanoue K, Kitano S, Hashizume M, Wada H, Sugimachi K. A rat model of esophageal varices. HEPATOLOGY 1991;13:353-358.
15. Bono RF, Moreno AH, Rousselot LM, Panke WF. Studies on portal hypertension. V. A comparison between the experimentallly induced state of portal hypertension and that observed in human beings. Surgery 1960;48:119-141.
16. Orda R, Ellis H. Self-established porto-caval and porto-pulmonary shunts in mechanically induced portal hypertension. Eur Surg Res 1978;10:172-183.
17. Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal-hypertensive rats: measurement with γ-labeled microspheres. Am J Physiol 1982;242:G156-G160.
18. Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, et al. Effects of long term administration of octreotide in portal vein stenosed rats. HEPATOLOGY 1996;23:537-543.
19. Stauber RE, Ruthardt FW, Tauxe WN, Van Thiel DH. Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds. Dig Dis Sci 1991;36:209-215.
20. Fernandez M, Garcia-Pagan JC, Casadevall M, Mourelle MI, Piqué JM, Bosch J, et al. Acute and chronic cyclooxygenase blockade in portalhypertensive rats: influence on nitric oxide biosynthesis. Gastroenterology 1996;110:1529-1535.
21. McCormick P, Biagini M, Dick R, Greenslade L, Chin J, Cardin F, et al. Octreotide inhibits the meal induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double blind placebo controlled study. HEPATOLOGY 1992;16:1180-1186.
22. Oberti F, Veal N, Kaassis M, Pilette C, Rifflet H, Trouvé R, et al. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol 1998;29:103-111.
23. Blei AT, O'Reilly DJ, Gottstein J. Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat. Gastroenterology 1984;86:1428-1436.